Optimization of methylated DNA markers to rule out endometrial cancer in patients with abnormal uterine bleeding.
Bakkum-Gamez JN, Harrington SP, Slettedahl SW, Berger CK, Krakowski KN, Lemens MA, Burger KN, Gonser AM, Taylor WR, Mahoney DW, Foote PH, Sherman ME, Laughlin-Tommaso SK, Hopkins MR, Butler KA, DeStephano CC, Schoolmeester JK, Phifer-Combs O, McCullagh K, AlHilli MM, Davidson ERW, Uribasterra P, Saad AH, Miller J, Kilts TM, Finkelstein K, Lievano G, Mills KA, Lessard-Anderson CR, Gattoc LP, Kroll L, Narula G, Schroeder P, Hanson H, Harings K, Krockenberger M, Beer TM, Kielar-Grevstad E, Gagrat BZ, Olson MC, Kisiel JB.
Bakkum-Gamez JN, et al. Among authors: beer tm.
Gynecol Oncol. 2026 Apr 10;208:91-99. doi: 10.1016/j.ygyno.2026.03.013. Online ahead of print.
Gynecol Oncol. 2026.
PMID: 41965218